Anika Therapeutics
Price & Volume
Stats
See more52W Range | $12.83-$29.11 |
Market Cap | $208.3M |
Shares Short | 388,746 |
Financials
See moreRevenue (12 Mos) | $119.9M |
Revenue Growth (YoY) | -28.8% |
Gross Profit (12 Mos) | $76.6M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • 26 days ago
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 2 months ago
Anika Completes Divestiture of Parcus Medical
Yahoo Finance • 2 months ago
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
About
CEO | Dr. Cheryl Renee Blanchard Ph.D. |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 288 |
